baber/WOPTO huggingface dataset:
Patent CA-3074877-A1 (CA)
Inventor: DEELSTRA JENTJE
IPC: A01J5/017
Filed: 2018-09-12
Abstract: A milking robot system (1) for milking of a dairy animal (2) with teats (3) comprises milking cups (12), a robot arm (11) for attaching the milking cups (12) to the teats (3), a teat detector (13) configured to detect the position of the teats (3), and a compressed air system (15) for providing dry compressed air to at least part of the milking robot system (1). The teat detector (13) comprises a housing (20) containing an optical sensor (21). The compressed air system (15) is operatively connectable with the inside of the housing (20) via an air line (18) in order to at least partly replace air which is present in the housing (20) by an amount of dry air from the compressed air system (15). This replacement operation may be performed directly, under pressure, or by first extracting air by means of an additional system and then replenishing it with dry air from the compressed air system (15). In this way, any moist air which may have penetrated in the housing (20) can be forced out in an efficient manner.
Patent CA-3076635-A1 (CA)
Title: Assessment of notch cellular signaling pathway activity using mathematical modelling of target gene expression
Inventor: VAN DE STOLPE ANJA
IPC: C12Q1/6809
Filed: 2018-09-28
Abstract: The present invention relates to a computer-implemented method for inferring activity of a Notch cellular signaling pathway in a subject based on expression levels of three or more target genes of the Notch cellular signaling pathway measured in a sample of the subject. The present invention further relates to an apparatus, to a non-transitory storage medium, and to a computer program for inferring activity of a Notch cellular signaling pathway in a subject. The present invention further relates to a kit for measuring expression levels of three or more target genes of the Notch cellular signaling pathway in a sample of a subject, to a kit for inferring activity of a Notch cellular signaling pathway in a subject, and to the use of such kits in performing the method.
Patent CA-3078706-A1 (CA)
Title: Sampling apparatus and method
Inventor: BROWN TED
IPC: G01N1/02
Filed: 2018-10-18
Abstract: Sampling of food products and/or surfaces can be efficiently carried out by providing an apparatus comprising a bag construction incorporating a sample collection material secured to an inside surface of the bag. The bag is of a size large enough to permit inversion of the bag to expose the sample collection material for collection of samples from surfaces, followed by re-inversion to enclose the sample collection material. Methods for sampling food products and/or surfaces for detection of pathogens, microbial contaminants and/or constituents in products or on surfaces are additionally contemplated.
Patent CA-3080939-A1 (CA)
Title: Insulating device backpack
Inventor: MUNIE JEFFREY CHARLES
IPC: B65D81/38
Filed: 2018-12-17
Abstract: An insulating device can include an aperture having a waterproof closure which allows access to the chamber within the insulating device. The closure can help prevent any fluid leakage into and out of the insulating device if the insulating device is overturned or in any configuration other than upright. The closure may also prevent any fluid from permeating into the chamber if the insulating device is exposed to precipitation, other fluid, or submersed under water. The insulating device may include a back panel support structure and shoulder straps allowing the device to be worn as a backpack. This construction results in an insulating chamber that is substantially impervious to water and other liquids when the closure is sealed.
Patent CA-3084396-A1 (CA)
Inventor: MOSKAL MICHAEL G
IPC: B29C35/00
Filed: 2020-06-19
Abstract: A moldable eraser kit includes a first silicone polymer, a second silicone polymer, an abrasive agent, a catalyst configured to catalyze a reaction between the first silicone polymer and the second silicone polymer at room temperature, and at least two containers such that the first silicone polymer, the second silicone polymer, and the catalyst are not all present in the same container. Also disclosed herein is a method of making an eraser including the steps of mixing a first silicone polymer, a second silicone polymer, a catalyst, an abrasive agent, and optionally one or more additives to form a mixture, the mixture being free of polyvinyl chloride. The method also includes molding the mixture to form a shape and curing the mixture in the shape at room temperature to form a molded eraser.
Patent CA-3085600-A1 (CA)
Title: 18f-labeled peptide ligands useful in pet and cerenkov luminescene imaging
Inventor: BABICH JOHN W
IPC: A61K51/08
Filed: 2018-12-20
Abstract: The present technology is directed to compounds, intermediates thereof, compositions thereof, medicaments thereof, and methods related to the imaging of mammalian tissue via 18F- labeled peptide ligands disclosed herein.
Patent CA-3085970-A1 (CA)
Title: Aerosol provision systems
Inventor: ZIELAZEK PAWEL
IPC: A24F40/60
Filed: 2018-12-19
Abstract: An aerosol provision system comprising a display module configured to display information relating to the aerosol provision system in a display region of a surface of the aerosol provision system and a user input module comprising measurement circuitry coupled to a plurality of sensor elements located around the display region to provide a plurality of sensing regions for detecting the presence of an object over the surface of the aerosol provision system around the display region.
Patent CA-3087184-A1 (CA)
Inventor: CARLSEN THOMAS NIKOLAI
IPC: G01N33/04
Filed: 2018-12-18
Abstract: A dry stick (180a, 180b, 180c) arranged to indicate at least one biomarker value of a milk sample of an animal (100) by a lateral flow test.The dry stick (180a, 180b, 180c) comprises a sample pad (310), comprising a reagent, configured to indicate at least one biomarker value of a received milk sample of an animal (100) by changing colours when exposed for milk comprising the biomarker;a porous membrane (320), configured to create a capillary flow of the milk sample, from the sample pad (310) through the porous membrane (320); an absorbent pad (330), comprising an absorbent configured to absorb superfluous milk from the porous membrane (320); and a porous desiccant, configured to absorb moisture from environmental air.
Patent CA-3090483-A1 (CA)
Title: Compositions de pemetrexed polyglutamate gamma et leurs utilisations
Inventor: NIYIKIZA CLET
IPC: A61K31/519
Filed: 2019-02-07
Abstract: L'invention concerne, d'une manière générale, des compositions de pémétrexed polyglutamaté gamma, y compris des véhicules d'administration tels que des liposomes contenant le pémétrexed polyglutamaté gamma, et des procédés de fabrication et d'utilisation des compositions de pémétrexed polyglutamaté gamma pour traiter des troubles hyperprolifératifs (par exemple, le cancer) et des troubles du système immunitaire (par exemple, une inflammation et des maladies auto-immunes telles que la polyarthrite rhumatoïde).
Patent CA-3093805-A1 (CA)
Inventor: WATANABE SATOSHI
IPC: C08J3/16
Filed: 2019-03-28
Abstract: Provided are spherical organic-inorganic composite particles that exhibit good biodegradability. Organic-inorganic composite particles according to the present invention contain 1-79 wt% of a silica component and 21-99 wt% of a biodegradable plastic. The organic-inorganic composite particles have an average particle diameter d1 of 0.5-25 µm, a true density of 1.03-2.00 g/cm3, and a sphericity of 0.80 or greater. A cosmetic in which the organic-inorganic composite particles possessing such characteristics are blended exhibits superior touch feel characteristics.
Patent CA-3094469-A1 (CA)
Inventor: HOWARD STEPHEN
IPC: A61M16/06
Filed: 2017-11-06
Abstract: A system (10) for delivering respiratory therapy to a patient comprises a patient interface device (20) for delivering pressurised gas to a patient, a connector system (60) for connection to a source of pressurised gas and a conduit system (40) fluidly connecting the connector system (60) to the patient interface device (20). The connector system (60) includes a plurality of closable ports (68, 32) that allow a plurality of different modes of respiratory therapy to be provided. The conduit system (40) may include a first gas line (42), a second gas line (46) and a third gas line (46). The second gas line (46) and third gas line (44) may be contained within the first gas line (42) along at least part of their length.
Patent CA-3095773-A1 (CA)
Inventor: HANSON ROBERT E
IPC: A23B4/048
Filed: 2019-04-08
Abstract: A system for measuring smoke absorption into food products includes a surrogate that reacts to a presence of smoke in air ambient to the surrogate and the food products; and the surrogate is configured to change a state to a preselected degree after an exposure to the smoke for a time sufficient to effect a predetermined amount of smoke absorption by a selected food product. A method of making the system for measuring smoke absorption into food products includes placing the surrogate in air ambient to the surrogate in a smokehouse where the food products are to be smoked, configuring the surrogate to change a state after an exposure to the smoke for a time sufficient to effect a predetermined amount of smoke absorption by the food products; and measuring the change of state of the surrogate.
Patent CA-3096653-A1 (CA)
Title: Method and manufacturing plant for producing a product
Inventor: ZEHNDER THOMAS
IPC: G05B17/02
Filed: 2020-10-21
Abstract: In order to improve the planning and implementation of the manufacture of a product in a manufacturing plant, the manufacturing plant (12) is modeled by means of a machine network plan (M), the machine network plan (M) modeling the manufacturing plant (12) as a network of manufacturing nodes (1), and the product to be manufactured being modeled by means of a product synthesis plan (S), the product synthesis plan (S) modeling the hierarchical structure of the product in the form of a tree of product synthesis nodes (2). The machine network plan (M) and the product synthesis plan (S) are linked with each other in a software-based manner to form a manufacturing sequence (F), by a manufacturing node (1) of the machine network plan (M) being selected for each operation node (0) of the product synthesis plan (S), which manufacturing node carries out the manufacturing process step to be carried out at the relevant operation node (0). The manufacturing sequence (F) is carried out in the manufacturing plant (12) by means of a system controller (11) in order to produce the product .
Patent CA-3099190-A1 (CA)
Title: Decentralized and automated data storage, processing and sharing system and related process
Inventor: GUERIN MARC
IPC: G06F11/16
Filed: 2019-05-02
Abstract: A computer-implemented process and a decentralized and automated data storage, processing and sharing system are provided. The system comprises a plurality of local units, comprising a local primary server located on premise of said given client and a local backup server remotely located on a different premise. The primary local server stores proprietary files and operational data relating to the configuration and operation of the server; and runs an operating system (OS); server-related applications, and client-specific applications. A central system periodically receives, for each of the local units, the operational data from the local primary server and from the local backup server, and automatically performs remote management; maintenance; and surveillance of the local units, based on the operational data received, without storing or accessing the proprietary files on the local primary servers and on the local backup servers.
Patent CA-3102614-A1 (CA)
Inventor: OTTING KRISTA
IPC: C11D17/00
Filed: 2019-06-14
Abstract: A stabilized multi-use solid activated bleach composition comprising: at least 50 wt-% of a solid active oxygen source; 0.1-50 wt-% of a bleach activating agent; and a C6-C18 fatty acid binding system; wherein the solid composition has less than 1 wt-% water and provides shelf stability at room temperature for at least about one year. A stabilized activated bleach solid block composition comprising: 50-90 wt-% of a solid active oxygen source; 10-45 wt-% of a bleach activating agent; and 0.1-10 wt-% of a C6-C18 fatty acid binding system, wherein the solid composition has less than 0.5 wt-% water and provides shelf stability at room temperature for at least one year. A method of stabilizing a solid block composition comprising: providing a binding system; wherein the binding system comprises a C6-C18 fatty acid; wherein the stable solid composition comprises the binding system, at least 50 wt-% of a solid active oxygen source, and a bleach activating agent, wherein the ratio of the active oxygen source to the bleach activating agent is between about 1:1 to about 2.5: 1, and wherein the solid composition has less than about 1 wt- % water; and wherein the solid composition retains at least 80% available oxygen and 80% available bleach active generated by the reaction of the active oxygen source and the bleach activating agent after 4 weeks at 37.8 °C. A method of cleaning, sanitizing and/or bleaching utilizing said composition.
Patent CA-3103967-A1 (CA)
Inventor: LIU ZHENGCHUN
IPC: G06F30/00
Filed: 2020-12-23
Abstract: ABSTRACT A method for designing a borehole tubular for use in a borehole. The method may include defining tubular sections that make up the borehole tubular, defining a downhole operation that will be conducted using the borehole tubular at a first timestamp, determining loads that will be applied to each of the tubular sections at respective specific depths along the borehole during the downhole operation at the first timestamp, determining a design limit envelope for each of the tubular sections at the first timestamp based on design parameters of the tubular section and the specific depth of the tubular section at the first timestamp, and displaying a three-dimensional (3D) plot of the design limit envelopes of the tubular sections and the loads applied to the tubular sections as a function of depth within the borehole on a display. 36 Date Recue/Date Received 2020-12-23
Patent CA-3104306-A1 (CA)
Inventor: GOYAL AASHISH
IPC: G16Z99/00
Filed: 2020-12-24
Abstract: Insertion of supplemental content into a virtual environment is automated using a machine learning model. The machine learning model is trained to calculate a confidence value that a candidate virtual object fits into a virtual environment based on an input that includes a candidate virtual object, a list of persistent virtual objects, and a list of temporary virtual objects.  The machine learning model is trained using the persistent and temporary objects displayed in the current virtual environment until it predicts that a selected virtual object fits into the current virtual environment. The trained machine learning model is then used to select a virtual object comprising supplemental content to be inserted as a new virtual object in the virtual environment.
Patent CA-3104340-A1 (CA)
Inventor: HOLLABAUGH CURTIS L
IPC: A61G7/10
Filed: 2019-08-21
Abstract: An inflatable device for lifting a patient includes an inflatable body having a top sheet and a bottom sheet attached along opposing side edges and forming at least one cavity there between, and a plurality of connecting members extending outwardly from the opposing side edges of the inflatable device.
Patent CA-3105079-A1 (CA)
Title: Thermostable phytase variants
Inventor: SKOV LARS KOBBEROEE
IPC: A01H5/00
Filed: 2011-03-25
Abstract: The present invention relates to a method for producing phytase variants which has at least 74% identity to a phytase derived from Citrobacter braakii and comprises at least two additional disulfide bonds as compared to this phytase. These phytase variants have modified, preferably improved, properties, such as thermostability, temperature profile, pH profile, specific activity, performance in animal feed, reduced protease sensitiliby, and/or an modified glycosylation pattern. The invention also relates to the variants produced, DNA encoding these phytases, methods of their production, as well as the use thereof, e.g. in animal feed and animal feed additives.
Patent CA-3108016-A1 (CA)
Inventor: KIRCHNER BRET M
IPC: G05D7/01
Filed: 2019-07-24
Abstract: L'invention concerne un dispositif de limitation d'évent (114) conçu pour être fonctionnellement accouplé à un évent d'échappement d'un régulateur de fluide. Le dispositif de limitation d'évent comprend un boîtier (250), un champignon (254) disposé dans le boîtier, et un élément de retenue (258) agencé pour retenir le champignon dans le boîtier. Le boîtier comporte un passage de fluide (310) qui s'étend entre une entrée de fluide (298) et une sortie de fluide (306). Le champignon est disposé mobile dans le boîtier, en réponse à une pression au niveau de la sortie de fluide, afin de commander l'écoulement de fluide à travers le passage de fluide. Le boîtier comprend un ou plusieurs dispositifs de retenue (382) qui viennent en prise avec l'élément de retenue pour retenir l'élément de retenue dans le boîtier.
Patent CA-3108229-A1 (CA)
Inventor: DE SMEDT STEFAAN
IPC: A61P35/00
Filed: 2019-09-17
Abstract: The present invention relates to a method and composition for optimized intracellular delivery of nucleic acids, in particular mRNA. In addition to mRNA, the composition, in particular a nanoparticle, may include a glycolipid antigen. Combinations with checkpoint inhibitors are also provided. The method and composition of the invention targets antigen presenting cells and is especially useful for immunotherapy and vaccination purposes.
Patent CA-3111589-A1 (CA)
Title: Methods of inhibition
Inventor: ASHBY REGAN SCOTT
IPC: A61P27/02
Filed: 2019-09-13
Abstract: Uses of dopamine, deuterated dopamine, a deuterated dopamine derivative such as deuterated L-dopa, or a pharmaceutically acceptable salt thereof, in inhibiting the development or progression of visual disorders, such as myopia, or a visual disorder associated with diabetic retinopathy or Parkinson's disease, are provided.
Patent CA-3111785-A1 (CA)
Title: Dopamine d3 receptor selective antagonists/partial agonists and uses thereof
Inventor: NEWMAN AMY HAUCK
IPC: C07D471/04
Filed: 2019-09-09
Abstract: Disclosed herein are novel methods of treating pain in a patient in need thereof by providing to the patient a selective dopamine D3 receptor antagonist/partial agonist which when used with an opioid analgesic, can mitigate the development of opioid dependence, by preventing the need for dose escalation while either maintaining the opioid analgesic effect or providing analgesia with a lower dose of the opioid. In addition, the D3 antagonists/partial agonists described herein may be used to augment the effectiveness of current Medication Assisted Treatment regimens (e.g. methadone or buprenorphine) for the treatment of opioid use disorders.
Patent CA-3112714-A1 (CA)
Title: System and method for migrating an application container between nodes on a network
Inventor: ENGUEHARD MARCEL PAUL SOSTHENE
IPC: H04L45/02
Filed: 2019-09-06
Abstract: Systems, methods, and computer-readable media for migrating an application container between nodes on a network while serving incoming request streams are disclosed. An interest packet for an application container may be received at an origin node from a destination node sent over an information centric network, the interest packet including a request for migrating the application container to the destination node. In response, the origin node may transfer a copy of the application container over the network and to the destination node. The origin node can then shut down the application container and transmit over interim network nodes and to the destination node, any remaining container state. The destination node may then update a routing plane for the information-centric network for routing network traffic for the application container to the destination node.
Patent CA-3114414-A1 (CA)
Inventor: NEIDHART WERNER
IPC: C07D401/14
Filed: 2019-10-23
Abstract: La présente invention concerne de nouveaux antagonistes du récepteur de l'adénosine A2B et des compositions pharmaceutiques comprenant lesdits antagonistes, ainsi que leurs utilisations dans le traitement et la prévention de troubles qui peuvent être susceptibles d'être atténués par l'antagonisme du récepteur A2B tel que l'asthme, la broncho-pneumopathie chronique obstructive (BPCO), la fibrose pulmonaire, les maladies vasculaires, les maladies allergiques, l'hypertension, la rétinopathie, le diabète sucré, les troubles inflammatoires du tractus gastro-intestinal, les maladies inflammatoires, les maladies auto-immunes, les maladies rénales, les troubles neurologiques et, en particulier, les cancers. En particulier, la présente invention concerne des composés de formule (I), dans laquelle R1 représente 1 à 3 substituants R1 identiques ou différents, ledit R1 étant indépendamment à chaque occurrence choisi parmi hydrogène, halogène, alkyle en C1-C8, haloalkyle en C1- C8, alcoxy en C1-C8, hydroxyalkyle en C1-C8 et alcoxyalkyle en C1-C8 ; Ra est choisi parmi phényle, pyridinyle, pyrimidinyle, thiazolyle, thiodiazolyle, oxazolyle, pyrazolyle et triazolyle, lesdits phényle, pyridinyle, thiazolyle, thiodiazolyle, oxazolyle, pyrazolyle et triazolyle étant indépendamment éventuellement substitués par un ou plusieurs substituants choisis parmi halogène, hydroxyle, cycloalkyle, cycloalkyle substitué par alkyle en C1-C4, alkyle en C1-C8, haloalkyle en C1-C8, alcoxy en C1-C8, alkylaminocarbonyle en C1-C8, hydroxyalkyle en C1-C8, dialkylamino en C1- C8 alkyle en C1-C8, aminoalkyle en C1-C8 et hétérocycle choisi parmi oxirane, oxétane, aziridine et azétidine, lesdits oxirane, oxétane, aziridine et azétidine étant indépendamment éventuellement substitués par halogène, hydroxyle, alkyle en C1-C4, haloalkyle en C1-C2, alcoxy en C1-C2 ; ou Ra est -CONHR', R' étant choisi parmi alkyle en C1-C8, cycloalkyle, aryle, hétéroaryle et alkyl-N-morpholino en C1-C8, lesdits aryle, hétéroaryle et alkyl-N-morpholino en C1-C8 étant indépendamment éventuellement substitués par [un ou plusieurs] substituants choisis parmi halogène, cycloalkyle, alkyle en C1-C8, alcoxy en C1-C8, hydroxalkyle en C1-C8 et alcoxyalkyle en C1-C8 ; Ar/Het est choisi parmi pyridinyle, phényle et oxazolyle, lesdits pyridinyle, phényle et oxazolyle étant indépendamment éventuellement substitués par un ou plusieurs substituants indépendamment choisis parmi halogène, cyano, alkyle en C1-C8, haloalkyle en C1-C8, alcoxy en C1-C8, hydroxyalkyle en C1-C8 et alcoxyalkyle en C1-C8 ; ou un sel pharmaceutiquement acceptable, or hydrate de ceux-ci.
Patent CA-3114635-A1 (CA)
Title: Systeme et procede de configuration automatisee de precision pour reseaux neuronaux profonds
Inventor: SABOORI EHSAN
IPC: G06N3/08
Filed: 2019-11-18
Abstract: L'invention concerne un système et un procédé de configuration automatisée de précision pour les réseaux neuronaux profonds. Le procédé comprend les étapes consistant à obtenir un modèle d'entrée et une ou plusieurs contraintes associées à une application et/ou à un dispositif ou processus cible utilisé dans l'application, configurés pour faire usage d'un réseau neuronal profond; apprendre une configuration optimale de faible précision de l'architecture à l'aide de contraintes, du jeu de données d'apprentissage, et du jeu de données de validation; et déployer la configuration optimale sur le dispositif ou le processus cible en vue de son utilisation dans l'application.
Patent CA-3116432-A1 (CA)
Title: Aqueous dispersion and aqueous coating composition
Inventor: XU JIANMING
IPC: C08F220/18
Filed: 2018-10-24
Abstract: An aqueous dispersion as a biobased binder and an aqueous coating composition comprising such aqueous dispersion and showing balanced stain resistance, freeze-thaw stability, and anti-clogging properties.